checkAd

     138  0 Kommentare Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes - Seite 3

    Media Contact:
    Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations
    Ireland +353 1 697 2141         U.S. +1 215 867 4910

    Investor Contact:
    Andrea N. Flynn, Ph.D., Vice President, Head, Investor Relations
    Ireland +353 1 634 7887         U.S. +1 561 306 4035

    Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

    Logo - https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_Logo.jpg

     

    Lesen Sie auch

     


    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes - Seite 3 DUBLIN, April 20, 2021 /PRNewswire/ - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company") announced today that its wholly owned subsidiary, Jazz Securities Designated Activity Company (the "Issuer"), is commencing a private offering (the …